Jitske van den Bulk

γδ T cells are effectors of immunotherapy in cancers with HLA class I defects

N. de Vries, Joris van de Haar, Vivien Veninga et al. · Nature · 2023 · 298 citations · Full text

Life Sciences, Immunology, Oncology +15

Identification of a neo-epitope dominating endogenous CD8 T cell responses to MC-38 colorectal cancer

Brett J. Hos, Marcel Camps, Jitske van den Bulk et al. · OncoImmunology · 2019 · 95 citations · Full text

Life Sciences, Immunology, Oncology +17

Neoantigen-specific immunity in low mutation burden colorectal cancers of the consensus molecular subtype 4

Jitske van den Bulk, Els M.E. Verdegaal, Dina Ruano et al. · Genome Medicine · 2019 · 63 citations · Full text

Life Sciences, Immunology, Oncology +17

CD103 and CD39 coexpression identifies neoantigen-specific cytotoxic T cells in colorectal cancers with low mutation burden

Jitske van den Bulk, Manon van der Ploeg, Marieke E. Ijsselsteijn et al. · Journal for ImmunoTherapy of Cancer · 2023 · 29 citations · Full text

Life Sciences, Immunology, Oncology +17

Combined evaluation of the FAS cell surface death receptor and CD8+ tumor infiltrating lymphocytes as a prognostic biomarker in breast cancer

Erik J. Blok, Jitske van den Bulk, N. Geeske Dekker-Ensink et al. · Oncotarget · 2017 · 24 citations · Full text

Life Sciences, Immunology, Oncology +17